In the United States, out-of-pocket (OOP) costs of brand-name medications for neurological disorders increased significantly from 2012 to 2021, with the largest hikes in multiple sclerosis (MS) drugs, ...

In critical care, the right medication at the right time can save a life—but the stakes are high, and errors can be devastating. New guidelines, essential drug lists, and team-based safety strategies ...